Osteoblast differentiation with titania and titania-silica-coated titanium fiber meshes. by Meretoja, V.V. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/49048
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
1489
INTRODUCTION
THE STANDARD TREATMENT of large bone defects in-volves transplantation of autologous or allogeneic
bone grafts. However, new approaches to manage such
defects are needed because of, for example, insufficient
supplies, donor site morbidity in relation to autografts,
risk of immune reactions, and transmission of disease in
relation to allografts. Tissue engineering is a rapidly de-
veloping area of reconstructive medicine in which tissue-
inducing factors and/or cells are combined with a scaf-
fold material to regenerate the structure and function of
the original tissue.1,2
Various growth factor–delivery system combinations
have been applied to enhance bone regeneration.3,4 How-
ever, the main body of work has concentrated on the
members of the transforming growth factor- superfam-
ily and their carrier matrices.5,6 These growth factors can
induce bone formation at a defect site through recruit-
ment of mesenchymal stem cells for proliferation and dif-
ferentiation toward an osteogenic lineage. Accordingly,
bone repair can also be enhanced through direct applica-
tion of osteogenic cells (possibly together with growth
factors) to tissue-engineering scaffolds before implanta-
tion.7,8 A good source of such cells is bone marrow con-
taining mesenchymal stem cells/osteoprogenitor cells
that can be expanded under cell culture conditions to
achieve sufficient numbers of cells for clinical appli-
cations (see Derubeis and Cancedda9 and references
therein).
An implanted bone-regenerative material should form
a direct contact with surrounding tissues, with no inter-
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vening fibrous capsule. It has been suggested that this re-
quirement can be met through use of bioactive materials,
on the surfaces of which deposition of calcium phosphate
takes place and specific proteins are incorporated in
vivo.10–12 Usually passive titanium surfaces can be ren-
dered bioactive by various means such as alkali–heat
treatment,13 anodic oxidation,14,15 or sol–gel-derived ti-
tania coatings.16 Our previous study showed that, in ad-
dition to bone contact, the sol–gel-derived TiO2 coatings
can also facilitate direct soft tissue attachment, with no
fibrous capsule formation.17 In many applications the lat-
ter can be as important as direct bonding to bone. We
also found that formation of a calcium phosphate min-
eral layer was not required for enhancement of soft tis-
sue contact.
Reactive ceramic coatings such as various calcium
phosphates and bioactive glasses have also been used to
improve attachment of titanium implants to tissues.18,19
However, such coatings are ultimately resorbed in vivo,
exposing underlying metal surfaces and perhaps result-
ing in loss of existing contact with tissue.20 On the other
hand, silica-containing dissolution products themselves
can have beneficial osteopromoting functions.21,22 Stable
TiO2 surfaces that release silica can be achieved through
use of titania–silica films derived from sol–gels. Such
mixed oxide films have been widely used in fields such
as catalysis,23 but there have been only a few studies of
their use as biomaterials.24–26 Thin films of this kind
seem to enhance fibroblast proliferation and osteoblast
differentiation in vitro.
Sintered titanium fiber meshes loaded with osteogenic
cells have previously shown potential as mechanically
strong bone graft substitute in vivo.27,28 In this study, we
applied titania and titania–silica sol–gel coatings to such
meshes and compared osteogenic activities under cell
culture conditions. To our knowledge, this is the first
study of these types of coatings in a three-dimensional
cell culture model.
MATERIALS AND METHODS
Scaffold preparation
The cell culture scaffolds were cut from a sintered ti-
tanium fiber mesh (Bekaert, Zwevegem, Belgium) with
a volumetric porosity of 86%, a density of 600 g/m2, and
a fiber diameter of 40 m. The average distance between
fibers was 250 m. Disk-shaped specimens (6 mm in di-
ameter and 0.8 mm thick) were used as such (cpTi) or
coated with titania (TiO2) or titania–silica (TiSi), using
the sol–gel technique described by Jokinen et al.26 with
slight modifications.
The titania sol was produced by dissolving tetraiso-
propyl orthotitanate (TIPOT) in ethanol and mixing this
with a solution containing ethylene glycol monoethyl
ether, deionized water, hydrochloric acid, and ethanol.
The sol was aged at 0°C for 24 h before dipping. The ti-
tania–silica sol was produced by mixing the TiO2 and
SiO2 sols described below to obtain a molar ratio of 30%
TiO2 and 70% SiO2. The SiO2 sol was prepared by mix-
ing tetraethyl orthosilicate, ethanol, and water at room
temperature, and adding nitric acid as a catalyst for hy-
drolysis. The sol was aged at 40°C for 60 min before use.
The TiO2 sol was prepared by mixing TIPOT, ethanol,
nitric acid, and water at room temperature. It was aged
at 40°C for 30 min before use. The final TiO2–SiO2 sol
was further aged at 40°C for 24 h and then cooled to 0°C
before the dipping process. The compositions and aging
times of the prepared sols are shown in Table 1.
The titanium fiber mesh substrates were cleaned ul-
trasonically in acetone (5 min) and ethanol (5 min) and
dried in air before each coating cycle. Coating was
achieved by dipping substrates into a sol and then with-
drawing them at a speed of 0.3 mm/s. The substrates were
then heated at 500°C for 10 min. The dipping and heat-
ing cycle was repeated two to five times. Uncoated and
coated scaffolds were finally cleaned ultrasonically and
sterilized with  radiation (minimum, 25 kGy).
Cell culture
Rat bone marrow osteoblast-like cells were obtained
and cultured as described by Maniatopoulos et al.29
Briefly, the femurs of four young male adult Sprague-
Dawley rats (weight, 140 to 160 g) were isolated for each
experiment. The bones were wiped with 70% alcohol and
immersed twice in -MEM (Sigma, St. Louis, MO) cul-
ture medium containing penicillin–streptomycin (100
units/mL, GIBCO; Invitrogen, Breda, The Netherlands).
The condyles were cut off and bone marrow was flushed
out with complete cell culture medium (-MEM, antibi-
otics supplemented with 15% fetal bovine serum [GIBCO],
ascorbic acid (50 g/mL; Sigma), 8.5 mM sodium -
TABLE 1. COMPOSITION AND AGING OF COATING SOLS
TiO2SiO2 Oxide content
(mol%) Ethanolalkoxide H2Oalkoxide Acidalkoxide (g/100 mL) Aging
1000 8.20 1.00 0.018 9.52 24 h at 0°C0
3070 6.72 1.06 0.100 9.97 24 h at 40°C
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glycerophosphate [Merck, Darmstadt, Germany], and 10
nM dexamethasone [Sigma]). The resulting suspension
was passed through a 20-gauge needle and plated cells
were cultured in a humidified 5% CO2 atmosphere at
37°C.
After 7 days of primary culture, the adherent cell 
population was enzymatically detached (0.25% trypsin–
0.02% EDTA [Sigma]) and a stock of 1.0  106 cells/mL
was prepared in complete culture medium. Cell suspen-
sion (0.1 mL per titanium mesh) was added to each
type of substrate in 15-mL polypropylene tubes. Cells
were allowed to adhere at 37°C for 3 h, with manual shak-
ing every 30 min. After seeding, the substrates were trans-
ferred to the wells of 24-well culture plates, with one
mesh per well containing 1 mL of fresh culture medium.
Culture was continued for up to 21 days, with replace-
ment of medium every 2 to 3 days. On the basis of light
microscopy of the culture plates, the scaffolds were trans-
ferred to clean culture wells every 7 days to ensure that
no extensive cell growth and/or mineral deposition took
place outside the titanium meshes. The whole cell cul-
ture process was repeated in two independent experi-
mental runs.
Alkaline phosphatase activity and amount 
of DNA
At predetermined time points, four replicate sub-
strates were washed with phosphate-buffered saline
(PBS) and transferred to microcentrifuge tubes con-
taining 1 mL of sterile water. The tubes were then in-
cubated at 37°C for 10 min and stored at 70°C. After
thawing, the samples were treated ultrasonically in an
ice–water bath for 10 min and the released amount of
DNA and alkaline phosphatase (ALP) activity were
measured from supernatant.
Amounts of DNA were measured in 100 L of su-
pernatant transferred to microtiter plates. Equal
amounts of PicoGreen double-stranded DNA (dsDNA)
quantitation reagent (Molecular Probes Europe, Leiden,
The Netherlands) were added to each well and incuba-
tion took place for 10 to 15 min at room temperature,
with protection from light. Fluorescence from three
replicate wells was measured with a Victor multilabel
counter (PerkinElmer Life and Analytical Sciences/
Wallac, Turku, Finland), at excitation and emission
wavelengths of 490 and 535 nm, respectively. Amounts
of DNA were read from a  phage dsDNA standard
curve.
To measure ALP activity, 50 L of supernatant was
transferred to a microtiter plate and 200 L of p-nitro-
phenyl phosphate substrate solution (Sigma) were
added. The plate was incubated at 37°C for 1 h and 50
L of a 3 M NaOH solution was added to each well to
stop the enzymatic reaction. Mean readings of ab-
sorbance from three replicate wells were recorded at 405
nm, using an enzyme-linked immunosorbent assay
(ELISA) plate reader (Multiskan MS; Labsystems,
Helsinki, Finland). Amounts of converted substrate
were read from a p-nitrophenol standard curve. ALP ac-
tivities measured were normalized in relation to
amounts of DNA determined.
Quantitation of matrix mineralization
At predetermined time points, four replicate substrates
were washed in PBS and transferred to 1 mL of 0.5 N
acetic acid. After 24 h of incubation at room tempera-
ture, with mild shaking, amounts of dissolved calcium in
the supernatant were determined. For each assay, fresh
reagent containing o-cresolphthalein complexone (50
g/mL) and 8-hydroxyquinol (1 mg/mL) in an ethano-
lamine–boric acid buffer was prepared. Five microliters
of standard or sample was pipetted onto a microtiter plate
and 300 L of reagent was added. After 10 min of in-
cubation at room temperature, absorbances from three
replicate wells were recorded at 560 nm, using an ELISA
plate reader. Calcium concentrations were read from a
CaCl2 standard curve.
Osteocalcin production
Amounts of osteocalcin (OC) produced by the cul-
tured cells were determined with a rat osteocalcin en-
zyme immunoassay (EIA) kit (Biomedical Technolo-
gies, Stoughton, MA). At predetermined time points,
four replicate substrates were washed in PBS and trans-
ferred to microcentrifuge tubes containing 1 mL of as-
say buffer and stored at 70°C. After thawing, the sam-
ples were treated ultrasonically in an ice–water bath for
10 min, and the OC released into the supernatant was
measured in accordance with the manufacturer’s in-
structions.
Scanning electron microscopy
Substrates to be subjected to scanning electron mi-
croscopy (SEM) were washed in PBS and fixed with
2% glutardialdehyde in a 100 mM cacodylic acid
buffer, pH 7.4. The fixed substrates were dried in a ris-
ing ethanol series (70 to 100%) and sputter-coated with
20 nm of gold. The samples were examined with a
JSM-5500 microscope (JEOL, Tokyo, Japan). The
presence of calcium and phosphorus within mineral de-
posits was verified by energy-dispersive X-ray spec-
troscopy (EDS) analysis (Princeton Gamma-Tech,
Rocky Hill, NJ).
Statistics
Statistical analyses were performed with the SPSS 
version 11.0 software package (SPSS, Chicago, IL). 
Data were analyzed by one-way analysis of variance
(ANOVA) followed by the Tukey post hoc test.
RESULTS
Proliferation
The highest initial DNA amounts were measured from
cpTi scaffolds (p  0.05), whereas there was no signifi-
cant difference between DNA release from TiO2 and TiSi
scaffolds by day 1 (Fig. 1). On cpTi and TiSi substrates
proliferation had already ceased by day 3, and the
amounts of DNA did not increase after that. On the other
hand, DNA release from TiO2 substrates increased until
day 7. The maximal amount of DNA per scaffold was
similar with all substrate types.
Differentiation markers
ALP activity, an early marker of osteoblast differenti-
ation, was measured after 1, 3, and 7 days of culture (Fig.
2). The maximal ALP activities for cpTi and TiO2 scaf-
folds were observed on days 3 and 7, respectively. With
TiSi substrates peak activity occurred by day 3, but with-
out reaching statistical significance (p  0.06). The lev-
els of maximal ALP activities were similar with all sub-
strate types.
A later differentiation marker, OC, was studied after 2
and 3 weeks of culture (Fig. 3). The highest amount of
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FIG. 1. Amounts of cellular DNA released from culture scaffolds. Columns represent means and error bars represent standard
deviations; *statistically significant difference (p  0.05) between the time points indicated.
FIG. 2. Alkaline phosphatase activities of cultured cells. Columns represent means and the error bars represent standard devi-
ations; *statistically significant difference (p  0.05) between the time points indicated.
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protein secreted by day 14 was found with TiO2 sub-
strates, the lowest with TiSi substrates (p  0.05). By day
21 the lowest OC secretion was still observed with TiSi
substrates, but there was no significant difference be-
tween protein levels with cpTi and TiO2 substrates.
Matrix mineralization
Mineral deposition was first observed, by means of
SEM, on day 5 with TiO2 scaffolds. With the other scaf-
folds mineralization did not occur before day 7. There
were no other perceptible differences between cell lay-
ers grown on the various substrates (Fig. 4). The extent
of matrix mineralization by osteoblasts was measured via
amounts of calcium deposited on the scaffolds (Fig. 5).
At both the 8- and 16-day time points, calcium deposi-
tion was greatest with the TiO2-coated substrates and
least with the TiSi-coated substrates (p  0.05).
DISCUSSION
It has been shown that cell-loaded titanium fiber scaf-
folds have bone-forming potential in ectopic30 and or-
thotopic rat models.27,28 Titanium meshes that were not
loaded with cells had only minor osteoconductive prop-
erties in these studies. In vivo data suggest that sol–gel
TiO2 coating can increase both bone and soft tissue at-
tachment to titanium implants.16,17 Under two-dimen-
sional culture conditions, cellular response has been
found to be further enhanced by incorporation of a solu-
ble silica phase in the coating.24 We therefore felt that
nonresorbable bioactive coatings based on titania, espe-
cially ones that released silica, might enhance the per-
formance of titanium fiber scaffolds. Why release of sil-
ica from a coating should have a favorable effect is not
clear. The silica concentrations in the cell culture medium
were approximately 10 times lower than those resulting
from dissolution of bioactive glasses (2 to 10 ppm of sil-
ica versus 35 to 85 ppm of silica). Such dissolution has
been shown to have osteopromotional effects.31,32 The
nanoscale structures of thin titania and titania–silica coat-
ings can be beneficial in relation to osteoblasts.33 How-
ever, whereas the chemical compositions of the sols used
in this work were similar to those in our previous stud-
ies, the topographies of the coatings on the scaffolds was
not similar. Investigation of the fiber meshes by SEM
showed that the coating layer was thick and extensively
cracked. The coatings on planar surfaces were much thin-
ner and crack free. The coatings were not characterized
further in this study.
Marked cellular expansion was observed with cpTi and
TiSi scaffolds between 1 and 3 days of culture, but only
minor proliferation was observed after further incubation.
With TiO2-coated meshes there was cellular expansion
for up to 7 days. However, maximal DNA release was
no greater than with the other types of matrix. An over-
all short proliferation phase corroborates our previous re-
sults,34,35 and can be explained on the basis of the high
concentration of cells (1  106/mL) used to seed the scaf-
folds. This would have resulted in numerous cell–cell 
interactions, and allowed rapid differentiation into the 
osteogenic lineage.36 Enhanced differentiation after high-
density seeding has also been reported with polymeric
scaffolds.37 The prolonged proliferation with TiO2 sub-
strates was reflected in later attainment of maximal ac-
tivity of the early osteoblast marker ALP in TiO2 matri-
ces than in the other matrices. Similar results have been
obtained when cell differentiation has been delayed be-
cause of an absence of osteogenic supplements during os-
teoblast preculture. In the experiments concerned, pro-
FIG. 3. Osteocalcin protein accumulation in scaffolds during cell culture. Columns represent means and error bars represent
standard deviations; *statistically significant difference (p  0.05) between scaffold types.
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liferation of cells inside porous scaffolds continued for
up to 2 weeks38 and 4 weeks,39 as long as ALP activity
was increasing. All of the findings are in accordance with
the notion that there is a reciprocal relationship between
proliferation and differentiation of osteogenic cells de-
rived from bone marrow and calvaria.40,41
In contrast to ALP measurements, the TiO2 scaffolds
exhibited enhanced osteocalcin protein incorporation into
the extracellular matrix. The amounts of OC with TiO2
scaffolds were greater than with cpTi scaffolds in early
cultures. However, OC levels did not increase between
14 and 21 days of culture, probably because protein re-
lease was compromised from highly mineralized sam-
ples. OC incorporation with TiSi scaffolds was signifi-
cantly less than with the other matrices. Our results are
consistent with those of Nishio et al.,42 who found en-
hanced osteoblast differentiation but not proliferation on
bioactive titania surfaces. Greater osteoblast proliferation
has been found with titania coatings than with uncoated
titanium alloy by Faust et al.43 They did not study cell
differentiation.
Marked mineralization of the scaffolds was observed
after 8 days of culture. At this time, the levels of calcium
were highest with TiO2-coated matrices, and lowest with
TiSi-coated matrices. TiO2 coatings are known to form
bonelike apatite layers on their surfaces in simulated body
fluid,44 and also to absorb calcium and phosphate ions in
the presence of proteins.17 However, the marked calcium
deposition with cpTi and TiSi scaffolds suggests that the
mineralization observed had a biological basis. The min-
eralization seen in the SEM micrographs was always as-
sociated with cells and the extracellular matrix. SEM
showed that there were mineral deposits on TiO2 scaf-
folds even on day 5. With the other types of scaffold min-
eralization was not perceptible until day 7. Mineraliza-
tion subsequently proceeded with equal effectiveness
with all of the materials. In those cultures, calcium de-
position on the scaffolds corresponded to a final Ca2
concentration of 0.8 mM after each change of medium.
This would seem to be a limit concentration that cannot
be exceeded under the standard culture conditions used
in this study (our unpublished observations).
The medium used for osteoblast culture routinely con-
tains sodium -glycerophosphate as an osteogenic sup-
plement.45 This is rapidly hydrolyzed by the ALP pro-
duced by the cells, with release of inorganic phosphate
into the medium.46,47 High phosphate concentrations can
then lead to spontaneous precipitation of calcium phos-
phate, even in the absence of cells.48 However, only mi-
nor amounts of mineral precipitation were observed by
means of light microscopy at the peripheries of culture
wells, and it was associated mostly with outgrowth of
cells from scaffolds. The calcium deposition on the sub-
strates corresponded more closely to levels of osteocal-
cin, a component of the extracellular matrix, than to lev-
els of ALP activity. This would indicate that most of the
calcium was deposited by mineralizing osteogenic cells
within the scaffolds rather than as a result of simple
chemical reactions in the solution.
The study described in this article included two inde-
pendent cell culture experiments. However, only one set
of data is reported in detail. The repeated study gave sim-
ilar relative results, with minor quantitative differences.
The current study confirms our previous findings that
titanium fiber mesh supports attachment, growth, and dif-
ferentiation of rat bone marrow stromal cells. Further-
more, the osteogenic capacities of cell–scaffold con-
structs under cell culture conditions were increased with
a sol–gel-derived titania coating, but not with a tita-
nia–silica coating.
FIG. 5. Calcium deposition on culture scaffolds. Columns represent means and the error bars represent standard deviations;
*statistically significant difference (p  0.05) between scaffold types.
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